Show simple item record

Authordc.contributor.authorVergara, Nicolás 
Authordc.contributor.authorEspinoza, Gloria 
Authordc.contributor.authorBalanda, Monserrat 
Authordc.contributor.authorQuiero, Andrea 
Authordc.contributor.authorHidalgo, Wilma 
Authordc.contributor.authorSan Martín, Héctor 
Authordc.contributor.authorRamírez, Alejandro 
Authordc.contributor.authorRamírez, Eugenio 
Admission datedc.date.accessioned2019-03-18T11:56:24Z
Available datedc.date.available2019-03-18T11:56:24Z
Publication datedc.date.issued2017
Cita de ítemdc.identifier.citationJournal of Medical Virology, 2017 ; 89 : 1646–1653
Identifierdc.identifier.issn10969071
Identifierdc.identifier.issn01466615
Identifierdc.identifier.other10.1002/jmv.24805
Identifierdc.identifier.urihttps://repositorio.uchile.cl/handle/2250/167106
Abstractdc.description.abstractHere, we evaluated the prevalence of Human Papillomavirus (HPV) in two groups of Chilean women. The first group consisted of 3235 womenaged 18-64 years attended in six primary care centers of Santiago. The second group consisted of 456 women 18-85 aged who consulted the Gynaecology Department of the Reference Hospital of Santiago. Samples were collected from October 2012 to February 2016. Cervical swabs were analyzed both HPV genotyping by PCR and Reverse Line Blot, and cervical cytology by Pap testing. Results showed a prevalence of 12.0% HPV positive, 10.3% high-risk (HR) HPV types positive, 3.9% low-risk (LR) HPV types positive, and 1.0% Pap positive in group 1. The most frequent types were 16, 66, and 59, with a prevalence of 3.0%, 1.6%, and 1.5%, respectively. The prevalence were 71.9% HPV positive, 67.3%HR-HPVtypes positive, 13.6% LR-HPV types positive, and 62.5% Pap positive in group 2. The most frequent types were 16, 31, and 58, with prevalence of 33.6%, 10.5%, and 7.0%, respectively. Among infected women with HPV: 7.6% were infected with HPV16 or HPV18, 3.0% with HPV31, HPV33 or HPV45, and 6.7% with any other HR-HPV. These findings show great difference in HPV prevalence and types between primary care and reference center, and provide useful epidemiological information to assess the impact of HPV vaccination in the future.
Lenguagedc.language.isoen
Publisherdc.publisherWiley
Type of licensedc.rightsAttribution-NonCommercial-NoDerivs 3.0 Chile
Link to Licensedc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/cl/
Sourcedc.sourceJournal of Medical Virology
Keywordsdc.subjectChilean women
Keywordsdc.subjectGenotypes
Keywordsdc.subjectHuman papillomavirus
Keywordsdc.subjectPrevalence
Títulodc.titlePrevalence of Human Papillomavirus infection among Chilean women from 2012 to 2016
Document typedc.typeArtículo de revista
Catalogueruchile.catalogadorlaj
Indexationuchile.indexArtículo de publicación SCOPUS
uchile.cosechauchile.cosechaSI


Files in this item

Icon

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivs 3.0 Chile
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivs 3.0 Chile